Joseph C. Griffin, III
Vice President of Regulatory Affairs and Quality Assurance, Compliance Officer
Mr. Joseph C. Griffin, III has more than 35 years of experience in the design, development, regulatory compliance and manufacturing of numerous leading-edge, cardiovascular devices. Mr. Griffin joined Intact Vascular in 2014 andVesper Medical in 2016. He serves as Vice President of Regulatory Affairs/Quality Assurance and Compliance Officer for both companies. Mr. Griffin is the official company representative for all domestic and international quality, regulatory and compliance activities.
Previously, he served as Vice President of Regulatory Affairs and Compliance Officer at Flexible Stenting Solutions, a subsidiary of Cordis Corporation. In this role, he executed various regulatory, quality, clinical and compliance duties that led to the Cordis acquisition in 2013. Before, Mr. Griffin founded Professional Catheter Corporation, where he served as President until the EP MedSystems acquisition in 1993. Upon acquisition, he was appointed Vice President of Regulatory Affairs and played a key role in EP MedSystems IPO in 1995 (NASDAQ: EPMD). He also served as Director of Research and Development at Oscor Medical Corporation and Director of Research, Development and Technical Services at Nova Medical Specialties, leading to its acquisition by B. Braun of America in 1987.
Mr. Griffin attended several academic institutions and earned numerous certificates in Medical Plastics Technology, Silicone & Polyurethane for Medical Applications, Advanced Medical Plastics, ISO 13485 and Auditing. He is a published co-author in the area of medical device thrombogenicity research and an inventor/co-inventor, who holds 15 medical device-related U.S. patents.